Christopher Wiltshire

Chief Executive Officer at Hematherix LLC

63 year

Health Technology

Consumer Services

Profile

Christopher Wiltshire is the founder of Hematherix LLC (founded in 2015),.
Ipt Bioconsulting LLC (founded in 2008), and Hemastasyx Ltd.
(founded in 2015) where he holds the title of Chief Executive Officer.
He previously worked as the Head of Business Transactions & Investments at The Pfizer Incubator LLC from 1998 to 2008.
From 2018 to 2022, he worked as the Executive Director & Chief Business Officer at Ovoca Bio Plc.
He also worked as the Head of Business Development & Licensing at La Jolla Pharmaceutical Co. Mr. Wiltshire graduated from the University of Cambridge and holds an MBA from the University of Virginia Darden School of Business.

Christopher Wiltshire active positions

Companies	Position	Start
Hematherix LLC	Chief Executive Officer	31/12/2014
Hemastasyx Ltd.	Chief Executive Officer	31/12/2014

All active positions of Christopher Wiltshire

Former positions of Christopher Wiltshire

Companies	Position	End
OVOCA BIO PLC	Director/Board Member	30/01/2022
Ipt Bioconsulting LLC	Founder	31/12/2014
The Pfizer Incubator LLC	Corporate Officer/Principal	31/12/2007
LA JOLLA PHARMACEUTICAL COMPANY	Corporate Officer/Principal	-

See the detail of Christopher Wiltshire's experience

Training of Christopher Wiltshire

University of Cambridge	Graduate Degree
University of Virginia Darden School of Business	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Wiltshire's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
OVOCA BIO PLC	Health Technology

Private companies	5
Hematherix LLC
Ipt Bioconsulting LLC
The Pfizer Incubator LLC
La Jolla Pharmaceutical Co. La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA.	Health Technology
Hemastasyx Ltd.

See company connections